# Is longevity only for the rich?

Men in Germany's poorest income group die 8.6 years earlier than the richest. Yet the strongest longevity evidence sits with the free stuff, not the 10,000 euro clinics.

Open an Instagram feed on longevity and you will meet a specific person. He has a whole-body MRI booked, a supplement drawer that reads like a chemistry set and an epigenetic test that tells him he is biologically 42 when his passport says 51. The clinic he visits in Berlin charges somewhere between 1,900 and 16,900 euros for a typical program. It is easy to conclude that living longer is a luxury good, priced out of reach for almost everyone. That conclusion is half right and half deeply wrong and the gap between the two halves is the most useful thing you can know about this whole field.

Let us be honest about the uncomfortable part first, because pretending money does not matter would be a lie.

Does money really buy extra years of life?

Yes and the German numbers are not small. The Robert Koch-Institut followed the long-running Socio-Economic Panel across 25 years and found that life expectancy at birth differs by 8.6 years between the poorest and the richest income group for men, and by 4.4 years for women. The blunter version of the same finding: 27 percent of men in the lowest income group die before they reach 65, against 14 percent in the highest. This is not a story about a few outliers. It is a steady gradient: each step up the income ladder tends to buy a bit more life.

The same split runs through the map. In March 2025 the Robert Koch-Institut published its "Lebenserwartungslücke" analysis, comparing the most and least deprived regions of Germany. In 2020 to 2022, men in the most deprived areas lived 7.2 years less than men in the least deprived ones. For women the difference was 4.3 years. Worse, the gap has grown. In the early 2000s it stood at 5.7 years for men and 2.6 for women. Life expectancy kept climbing in the least deprived areas while it stalled in the most deprived ones from the mid-2010s, then fell there during the pandemic.

Why does this happen? Very little of it is the 300 euro epigenetic test. It is chronic stress, worse working conditions, more smoking, less time and money for good food, worse access to preventive care and neighborhoods where the classic German Sunday walk has nowhere to happen. Poverty steals years through a thousand small doors, not one expensive one. Anyone who tells you longevity is purely a matter of personal choice is ignoring a very solid pile of evidence.

So the steelman for "longevity is for the rich" is real. Now the twist.

Which longevity interventions actually have the strongest evidence?

The cheapest ones. This is the part almost nobody selling a longevity product wants you to sit with. When you rank interventions by the quality and size of their evidence, the top of the list is dominated by things that cost nothing or almost nothing. That does not mean supplements do nothing. Where something is genuinely missing, vitamin D through a northern winter, B12 on a plant-based diet, iron, omega-3 or simply protein, supplementing is well evidenced and cheap. The difference is whether you are closing a real gap or buying a promise of extra years.

Start with walking. A 2023 meta-analysis led by Maciej Banach pooled 17 studies covering roughly 227,000 people. Every extra 1,000 steps per day was linked to a 15 percent lower risk of dying from any cause. The benefit shows up far below the famous 10,000: the analysis measured against a baseline of roughly 3,900 steps a day, and the steepest gains land between about 6,000 and 10,000 steps for people over 60 and 7,000 to 13,000 for younger adults. Past those ranges the curve kept falling rather than flattening, all the way out to about 20,000. You do not need 10,000. You need a pair of shoes and a reason to leave the house.

Cardiorespiratory fitness is even more striking. In a 2018 study in JAMA Network Open, Cleveland Clinic researchers tracked 122,007 adults who had done treadmill testing. People in the lowest fitness category carried roughly five times the adjusted long-term mortality risk of the fittest (adjusted hazard ratio around 5.0); put the other way round, the fittest had about 80 percent lower risk. That effect was larger than smoking, high blood pressure or diabetes in the same data. And there was no upper limit: fitter was better, all the way up. This is close to what your VO2max measures, the maximum rate at which your body can take in and use oxygen at full effort. The Cleveland Clinic team used no gas mask; they estimated fitness in METs from treadmill speed and incline, which tracks the same underlying capacity. You can improve it with nothing more than a bike, a hill or a set of stairs.

A quick personal note, since I built these calculators myself: you can estimate your VO2max with the VO2max calculator here, no lab and no signup. It is only an estimate, but it gives you a number to measure against again in three months.

Why do doctors care so much about grip strength?

Because a cheap handgrip test predicts death surprisingly well. In a 2015 Lancet paper from the PURE study, Darryl Leong and colleagues measured grip strength in nearly 140,000 people across 17 countries. Each 5 kilogram drop in grip was associated with a 16 percent higher risk of dying from any cause. Grip strength predicted mortality better than systolic blood pressure did. A hand dynamometer costs about as much as one bottle of a fashionable supplement and you can check where you stand with the grip-strength tool here.

Grip is really a proxy for total muscle and muscle is something you build with resistance training. A 2022 meta-analysis by Haruki Momma and colleagues reviewed 16 cohort studies. Across the seven covering death from any cause, more than 260,000 people, regular strength work was tied to a 15 percent lower risk of dying, with reductions of 10 to 17 percent for heart disease, cancer and diabetes. The interesting detail: the biggest benefit showed up at just 30 to 60 minutes per week, and above roughly 140 minutes the measured advantage faded out. That is two short sessions. Bodyweight squats, a resistance band and a few water bottles will get you most of the way there.

Muscle also needs raw material, which means protein. The PROT-AGE group, an international panel convened by the European Union Geriatric Medicine Society, recommends that healthy older adults eat at least 1.0 to 1.2 grams of protein per kilogram of body weight per day, and 1.2 or more for those who train. That is above the 0.8 grams long used as the adult reference value, though the German Nutrition Society has itself moved to 1.0 for the over-65s. For a 70 kilogram person that is roughly 70 to 84 grams: a tub of quark, two eggs, a portion of lentils and a palm-sized piece of fish or chicken, which is more food than most people picture. Quark, eggs and beans are among the cheapest foods in any German supermarket.

Is sleep really as important as exercise?

Almost and one part of it may matter more than people assume. A 2024 study in the journal Sleep analyzed accelerometer data from 60,977 UK Biobank participants and scored them on the Sleep Regularity Index, an established measure of how consistent your sleep and wake times are day to day. Across the four most regular fifths of the group, risk of death ran 20 to 48 percent lower than in the least regular fifth, with the most regular sleepers at the far end of that range. What matters most: regularity predicted mortality better than sleep duration did. Going to bed and getting up at roughly the same time, weekends included, is free. It is also, for many people, harder than buying a gadget, which is exactly why the gadget sells.

And then there is the intervention almost no clinic can package, because it is other people.

How much does social connection affect how long you live?

A lot, on the scale of major medical risk factors. The landmark work here is a 2010 meta-analysis in PLoS Medicine by Julianne Holt-Lunstad and colleagues, pooling 148 studies and 308,849 people. Individuals with stronger social relationships had 50 percent greater odds of surviving the follow-up period than those with weaker ties. The effect was comparable in size to well-known risks like smoking and larger than obesity or physical inactivity in that analysis.

This is where a community actually beats a clinic. A regular walking group, a shared meal, a Saturday event where you know people's names: these are not a soft add-on to the science. They are exactly what the research keeps measuring. That evidence is observational, so it cannot prove that showing up adds years, but the association is among the most consistent in the field. The chapters, events and the map on this platform exist for exactly this reason and joining costs nothing. If you want a single move that does the most work, one that is both social and physical, walk to an event with someone rather than driving alone.

Notice what all of these share. Walking, fitness, strength, protein, sleep regularity and connection are either free or nearly free and every one of them rests on large studies with hard mortality outcomes. This is the strongest tier of evidence in the entire field and it is the cheapest.

What about the expensive tier: does it work?

This is where the story flips. The most expensive interventions tend to have the weakest evidence, sometimes almost none in humans.

Take epigenetic age tests, often sold for a few hundred euros with the promise of telling you your "true" biological age. The problem is reliability. A 2022 study in Nature Aging by Albert Higgins-Chen and colleagues split blood samples and ran them twice, in separate batches. Six widely used epigenetic clocks disagreed with themselves by a median of one to two years, and in the worst case by nearly nine. Either way, a single test result that says you are "three years younger" sits inside the noise band, so it is not something to build decisions on. The same authors showed the problem is fixable: rebuilding the clocks on principal components cuts the typical disagreement to well under a year. In plain terms, instead of reading individual spots in the genome, each carrying its own noise, you bundle many of them into a few stable composite scores, so the signal survives while most of the randomness averages out. Most consumer tests do not use the rebuilt versions. These tools are genuinely promising for research. As a personal report card, they are not there yet.

Supplement stacks are a similar story. Three of the most hyped longevity molecules of the last decade have not delivered on what they were sold for. A 2024 systematic review of almost 200 resveratrol trials concluded there is no conclusive clinical evidence to advocate its recommendation in any healthcare setting. The reason is not that the compound does nothing, but that after twenty years there is still no consensus dose and no large trial with clearly defined endpoints. For NMN, a compound sold to boost the cellular molecule NAD+, a 2025 meta-analysis of randomized trials covering NMN and the related nicotinamide riboside found no benefit for muscle mass, strength or physical function in older adults. Taurine had a promising 2023 result in Science, built on the premise that taurine levels fall with age. In June 2025 a team at the US National Institute on Aging published in the same journal that taurine actually rises or holds steady with age across three human cohorts, monkeys and mice. The premise did not hold. Each of these molecules moves some intermediate marker, blood pressure or inflammation. None has been shown to slow human aging. That is not a reason to tear up your stack today: for NMN, nicotinamide riboside and taurine the question is open rather than settled against them, and trials are still running. What it does mean is that paying premium prices today buys hope, not proof.

The full clinic checkups sit at the top of the price ladder and the spread is enormous. German radiology-led check-ups that include a whole-body MRI list from around 1,250 to 2,700 euros, while Berlin longevity clinics charge about 7,600 for a package adding a multi-cancer liquid biopsy and 16,900 for one adding genome sequencing and epigenetic clocks. This is prevention at a high level, with experienced doctors and machines almost no practice keeps in house, and a lot of it, appropriate cancer screening above all, is genuinely valuable. The thing worth wishing for is that this quality reaches everyone eventually, not only the people who can pay five figures. Two things are still worth knowing. A whole-body MRI of a healthy person also turns up incidental findings that would never have harmed you, and those pull you into biopsies and worry. And the evidence that these packages, as packages, add years is thin. Which is why what matters most is who reads the images and who puts them in context for you afterwards.

Does that mean the rich are wasting their money?

Not entirely and this is where fairness matters. Wealth buys some real things: earlier and better cancer screening, faster access to specialists, less financial stress and the time to actually cook, sleep and train. A good longevity clinic that catches a treatable cancer early has done something valuable. The mistake is assuming the price tag tracks the benefit. It often runs the other way. The 20 euro habit usually beats the 10,000 euro program, because the 20 euro habit is what the biggest studies actually measured.

So the real inequality is not that poor people cannot afford NMN. It is that they have less time, safety, green space and slack in their lives to do the free things that work. That is a structural problem and it is worth naming honestly rather than papering over with the idea that anyone can just choose to be healthy.

Does German health insurance actually pay for prevention?

Yes and most people leave the money on the table. Under paragraph 20 of the Fifth Social Code (SGB V), every statutory health insurer in Germany must provide for prevention in its statutes. Whether it subsidises a specific course is each insurer's own decision though: the law says it may, not that it must. In practice most cover up to two certified prevention courses per calendar year, usually 80 to 100 percent of the fee, often somewhere around 75 to 150 euros per course. That ceiling of two comes from the GKV-Spitzenverband guidance rather than the law, and some insurers cap the whole year instead of each course, so check your own terms. That covers things like nutrition courses, stress management, back training and structured exercise programs. Many Krankenkassen add a bonus program on top that pays you for documented gym visits, checkups or a completed course.

So the tier of interventions with the best evidence is also the cheapest and part of it is subsidized by your insurer. A prevention course, a bit of protein, a regular bedtime, two short strength sessions a week and a standing plan to see people you like: that is a longevity protocol that costs close to nothing and it is the one the largest studies with real mortality data actually support. The 300 euro test can wait until the science catches up. Your next walk cannot and it is free.

---

_Canonical: https://longevity-germany.com/en/articles/is-longevity-only-for-the-rich · Part of Longevity Cities · Updated 2026-07-30_